An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision

Axial spondyloarthritis (axSpA) is a group of debilitating, chronic, rheumatic conditions characterized by inflammation and new bone formation, mainly involving the spine and the sacroiliac joints. The lack of biomarkers in axSpA is well known. Despite significant treatment advances in recent years...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenzin, Mariagrazia, Ometto, Francesca, Ortolan, Augusta, Felicetti, Mara, Favero, Marta, Doria, Andrea, Ramonda, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315656/
https://www.ncbi.nlm.nih.gov/pubmed/32636944
http://dx.doi.org/10.1177/1759720X20934277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315656/
https://www.ncbi.nlm.nih.gov/pubmed/32636944
http://dx.doi.org/10.1177/1759720X20934277

Ejemplares similares